{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:31:15Z","timestamp":1790382675039,"version":"4.1.0"},"reference-count":44,"publisher":"Impact Journals, LLC","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,5,3]]},"DOI":"10.18632\/oncotarget.8241","type":"journal-article","created":{"date-parts":[[2016,3,21]],"date-time":"2016-03-21T22:41:33Z","timestamp":1458600093000},"page":"25640-25651","source":"Crossref","is-referenced-by-count":65,"title":["Argon protects against hypoxic-ischemic brain injury in neonatal rats through activation of nuclear factor (erythroid-derived 2)-like 2"],"prefix":"10.18632","volume":"7","author":[{"given":"Hailin","family":"Zhao","sequence":"first","affiliation":[{"name":"Department of Surgery and Cancer, Section of Anaesthetics, Pain Medicine and Intensive Care, Faculty of Medicine, Imperial College London, Chelsea & Westminster Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sian","family":"Mitchell","sequence":"additional","affiliation":[{"name":"Department of Surgery and Cancer, Section of Anaesthetics, Pain Medicine and Intensive Care, Faculty of Medicine, Imperial College London, Chelsea & Westminster Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Ciechanowicz","sequence":"additional","affiliation":[{"name":"Department of Surgery and Cancer, Section of Anaesthetics, Pain Medicine and Intensive Care, Faculty of Medicine, Imperial College London, Chelsea & Westminster Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinead","family":"Savage","sequence":"additional","affiliation":[{"name":"Department of Surgery and Cancer, Section of Anaesthetics, Pain Medicine and Intensive Care, Faculty of Medicine, Imperial College London, Chelsea & Westminster Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianlong","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Xuanwu Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xunming","family":"Ji","sequence":"additional","affiliation":[{"name":"Department of Neurosugery, Xuanwu Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daqing","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Surgery and Cancer, Section of Anaesthetics, Pain Medicine and Intensive Care, Faculty of Medicine, Imperial College London, Chelsea & Westminster Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,3,21]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"324","DOI":"10.2174\/157015910793358150","article-title":"Pharmacological neuroprotection after perinatal hypoxic-ischemic brain injury","volume":"8","author":"van Bel","year":"2010","journal-title":"Curr Neuropharmacol"},{"key":"2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1055\/s-2000-9293","article-title":"Hypoxic-ischemic encephalopathy","volume":"17","author":"Vannucci","year":"2000","journal-title":"Am J Perinatol"},{"key":"3","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1161\/01.STR.0000198867.31134.ac","article-title":"Xenon provides short-term neuroprotection in neonatal rats when administered after hypoxia-ischemia","volume":"37","author":"Thoresen","year":"2006","journal-title":"Stroke"},{"key":"4","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0165-0173(99)00009-0","article-title":"Pathophysiology of perinatal brain damage","volume":"30","author":"Garnier","year":"1999","journal-title":"Brain Res Brain Res Rev"},{"key":"5","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1542\/peds.100.6.1004","article-title":"Interventions for perinatal hypoxic-ischemic encephalopathy","volume":"100","author":"Perlman","year":"1997","journal-title":"Pediatrics"},{"key":"6","doi-asserted-by":"crossref","first-page":"c363","DOI":"10.1136\/bmj.c363","article-title":"Neurological outcomes at 18 months of age after moderate hypothermia for perinatal hypoxic ischaemic encephalopathy: synthesis and meta-analysis of trial data","volume":"340","author":"Azzopardi","year":"2010","journal-title":"Bmj"},{"key":"7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1469-8749.2003.tb00854.x","article-title":"Whole-body cooling after perinatal asphyxia: a pilot study in term neonates","volume":"45","author":"Zupan","year":"2003","journal-title":"Dev Med Child Neurol"},{"key":"8","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.neulet.2009.05.069","article-title":"Neuroprotection (and lack of neuroprotection) afforded by a series of noble gases in an in vitro model of neuronal injury","volume":"460","author":"Ma","year":"2009","journal-title":"Neurosci Lett"},{"key":"9","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.clp.2009.07.011","article-title":"Hypoxic-ischemic encephalopathy in the term infant","volume":"36","author":"Johnston","year":"2009","journal-title":"Clin Perinatol"},{"key":"10","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.redox.2012.10.001","article-title":"The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer","volume":"1","author":"Levonen","year":"2013","journal-title":"Redox Biol"},{"key":"11","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1146\/annurev-pharmtox-011112-140320","article-title":"Role of nrf2 in oxidative stress and toxicity","volume":"53","author":"Ma","year":"2013","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"12","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1167\/iovs.07-1099","article-title":"Essential roles of the PI3 kinase\/Akt pathway in regulating Nrf2-dependent antioxidant functions in the RPE","volume":"49","author":"Cai","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"13","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/sj.jcbfm.9600184","article-title":"Xenon preconditioning reduces brain damage from neonatal asphyxia in rats","volume":"26","author":"Maze","year":"2006","journal-title":"J Cereb Blood Flow Metab"},{"key":"14","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1097\/CCM.0b013e3182452164","article-title":"The protective profile of argon, helium, and xenon in a model of neonatal asphyxia in rats","volume":"40","author":"Ma","year":"2012","journal-title":"Crit Care Med"},{"key":"15","doi-asserted-by":"crossref","first-page":"R206","DOI":"10.1186\/cc8214","article-title":"Argon: neuroprotection in in vitro models of cerebral ischemia and traumatic brain injury","volume":"13","author":"Coburn","year":"2009","journal-title":"Critical care"},{"key":"16","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/cc9051","article-title":"Bench-to-bedside review: Molecular pharmacology and clinical use of inert gases in anesthesia and neuroprotection","volume":"14","author":"Franks","year":"2010","journal-title":"Crit Care"},{"key":"17","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1097\/CCM.0b013e31821209be","article-title":"Neuroprotective effects of argon in an in vivo model of transient middle cerebral artery occlusion in rats","volume":"39","author":"Coburn","year":"2011","journal-title":"Critical care medicine"},{"key":"18","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/j.1460-9568.2011.07786.x","article-title":"Increased p38 mitogen-activated protein kinase signaling is involved in the oxidative stress associated with oxygen and glucose deprivation in neonatal hippocampal slice cultures","volume":"34","author":"Black","year":"2011","journal-title":"Eur J Neurosci"},{"key":"19","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1124\/mol.107.035360","article-title":"Translational control of nrf2 protein in activation of antioxidant response by oxidants","volume":"72","author":"Chen","year":"2007","journal-title":"Mol Pharmacol"},{"key":"20","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1124\/mol.65.5.1238","article-title":"NAD(P)H:quinone oxidoreductase 1: role as a superoxide scavenger","volume":"65","author":"Ross","year":"2004","journal-title":"Mol Pharmacol"},{"key":"21","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/cc8847","article-title":"Argon neuroprotection","volume":"14","author":"Maze","year":"2010","journal-title":"Crit Care"},{"key":"22","doi-asserted-by":"crossref","first-page":"e30934","DOI":"10.1371\/journal.pone.0030934","article-title":"Ex vivo and in vivo neuroprotection induced by argon when given after an excitotoxic or ischemic insult","volume":"7","author":"Abraini","year":"2012","journal-title":"PloS one"},{"key":"23","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1096\/fj.04-2591hyp","article-title":"Nrf2, a multi-organ protector?","volume":"19","author":"Johnson","year":"2005","journal-title":"FASEB J"},{"key":"24","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.bcp.2012.11.016","article-title":"The Nrf2 cell defence pathway: Keap1-dependent and -independent mechanisms of regulation","volume":"85","author":"Park","year":"2013","journal-title":"Biochem Pharmacol"},{"key":"25","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.redox.2012.10.001","article-title":"The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer","volume":"1","author":"Levonen","year":"2013","journal-title":"Redox Biol"},{"key":"26","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/hipo.20934","article-title":"Acetyl-L-carnitine-mediated neuroprotection during hypoxia is attributed to ERK1\/2-Nrf2-regulated mitochondrial biosynthesis","volume":"22","author":"Singh","year":"2012","journal-title":"Hippocampus"},{"key":"27","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1096\/fj.12-217257","article-title":"The transcription factor NF-E2-related factor 2 (Nrf2): a protooncogene?","volume":"27","author":"Jaiswal","year":"2013","journal-title":"FASEB J"},{"key":"28","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1523\/JNEUROSCI.4043-13.2014","article-title":"Omega-3 fatty acids protect the brain against ischemic injury by activating Nrf2 and upregulating heme oxygenase 1","volume":"34","author":"Zhang","year":"2014","journal-title":"J Neurosci"},{"key":"29","doi-asserted-by":"crossref","first-page":"680","DOI":"10.4049\/jimmunol.181.1.680","article-title":"The transcription factor Nrf2 is a therapeutic target against brain inflammation","volume":"181","author":"Cuadrado","year":"2008","journal-title":"J Immunol"},{"key":"30","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/jnc.13115","article-title":"Neuroprotective effects of Argon are mediated via an ERK-1\/2 dependent regulation of heme-oxygenase-1 in retinal ganglion cells","volume":"134","author":"Goebel","year":"2015","journal-title":"J Neurochem"},{"key":"31","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev.pharmtox.010909.105600","article-title":"Mechanisms of cell protection by heme oxygenase-1","volume":"50","author":"Soares","year":"2010","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"32","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrc839","article-title":"The phosphatidylinositol 3-Kinase AKT pathway in human cancer","volume":"2","author":"Sawyers","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"33","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.neuroscience.2009.10.063","article-title":"Xenon preconditioning confers neuroprotection regardless of gender in a mouse model of transient middle cerebral artery occlusion","volume":"165","author":"Ma","year":"2010","journal-title":"Neuroscience"},{"key":"34","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/msb.2009.4","article-title":"PI3K-dependent cross-talk interactions converge with Ras as quantifiable inputs integrated by Erk","volume":"5","author":"Haugh","year":"2009","journal-title":"Mol Syst Biol"},{"key":"35","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1258\/ebm.2010.009366","article-title":"Effect of noble gases on oxygen and glucose deprived injury in human tubular kidney cells","volume":"235","author":"Ma","year":"2010","journal-title":"Exp Biol Med (Maywood)"},{"key":"36","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ejphar.2011.10.045","article-title":"The noble gas argon modifies extracellular signal-regulated kinase 1\/2 signaling in neurons and glial cells","volume":"674","author":"Coburn","year":"2012","journal-title":"European journal of pharmacology"},{"key":"37","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/ana.20547","article-title":"Xenon and hypothermia combine to provide neuroprotection from neonatal asphyxia","volume":"58","author":"Maze","year":"2005","journal-title":"Annals of neurology"},{"key":"38","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/jcbfm.2010.220","article-title":"Animal research: reporting in vivo experiments--the ARRIVE guidelines","volume":"31","author":"Altman","year":"2011","journal-title":"J Cereb Blood Flow Metab"},{"key":"39","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/ana.410090206","article-title":"The influence of immaturity on hypoxic-ischemic brain damage in the rat","volume":"9","author":"Brierley","year":"1981","journal-title":"Ann Neurol"},{"key":"40","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.brainres.2010.02.074","article-title":"The phosphatidylinositol-3 kinase\/Akt pathway mediates geranylgeranylacetone-induced neuroprotection against cerebral infarction in rats","volume":"1330","author":"Kobayashi","year":"2010","journal-title":"Brain Res"},{"key":"41","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1471-4159.2004.02324.x","article-title":"Hypoxia-induced ischemic tolerance in neonatal rat brain involves enhanced ERK1\/2 signaling","volume":"89","author":"Bergeron","year":"2004","journal-title":"J Neurochem"},{"key":"42","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jneuroim.2006.10.003","article-title":"SOD1 overexpression alters ROS production and reduces neurotoxic inflammatory signaling in microglial cells","volume":"182","author":"Bruce-Keller","year":"2007","journal-title":"J Neuroimmunol"},{"key":"43","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/1742-2094-8-129","article-title":"Generation of reactive oxygen species in 1-methyl-4-phenylpyridinium (MPP+) treated dopaminergic neurons occurs as an NADPH oxidase-dependent two-wave cascade","volume":"8","author":"Jones","year":"2011","journal-title":"J Neuroinflammation"},{"key":"44","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1097\/CCM.0b013e3182452164","article-title":"The protective profile of argon, helium, and xenon in a model of neonatal asphyxia in rats","volume":"40","author":"Ma","year":"2012","journal-title":"Crit Care Med"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.8241","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T05:32:19Z","timestamp":1718429539000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.8241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,21]]},"references-count":44,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2016,5,3]]}},"alternative-id":["8241","27016422"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.8241","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,21]]}}}